Pseudoephedrine Behind-The-Counter Limits Loom In Patchwork Of State Bills
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Attorney General would be required to report to Congress on the effectiveness of state efforts to prevent methamphetamine precursor diversion under a House bill introduced March 2
You may also be interested in...
Pseudoephedrine Restrictions Gain Steam Among Consumers, Survey Says
A moderate federal meth control law limiting pseudoephedrine products to behind retail counters would garner the support of the Food Marketing Institute and National Consumers League, the groups announced April 4
Industry Seeks Options As States Put Pseudoephedrine Behind The Counter
Passage of laws in Iowa and Kentucky restricting pseudoephedrine to behind-the-counter sale follows a similar methamphetamine precursor control bill in Arkansas
Australian “Project Pseudo” Puts Meth Precursor Down Under The Counter
The Pharmacy Guild of Australia is taking measures to voluntarily place behind-the-counter restrictions on pseudoephedrine products in order to avoid the drug's reclassification